Vertex Pharma Capital Expenditure — Historical Data
Vertex Pharma (VRTX) capital expenditure was $438M in FY2025 (+47% YoY). The tables below show the complete quarterly and annual capital expenditure history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Capital Expenditure
Fiscal Year
Capital Expenditure
YoY
2025
$438M
+47%
2024
$298M
+15%
2023
$258M
+26%
2022
$205M
-13%
2021
$235M
-10%
2020
$260M
+245%
2019
$75M
-21%
2018
$95M
-4%
2017
$99M
+76%
2016
$57M
-55%
2015
$125M
+105%
2014
$61M
+19%
2013
$51M
-28%
2012
$71M
-25%
2011
$95M
+149%
2010
$38M
+62%
2009
$23M
-27%
2008
$32M
Recent Quarterly Capital Expenditure
Quarter
Capital Expenditure
Q1 2026
$133M
Q4 2025
$149M
Q3 2025
$102M
Q2 2025
$146M
Q1 2025
$41M
Q4 2024
$93M
Q3 2024
$68M
Q2 2024
$69M
Q1 2024
$68M
Q4 2023
$116M
Q3 2023
$41M
Q2 2023
$60M
Source: VRTX on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.